# Bronchial Alpha Amylase as a Marker for Early Aspiration Pneumonia in Therapeutic Hypothermia.

> **NCT03007862** · — · UNKNOWN · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 150 (estimated)

## Conditions studied

- Early Aspiration Pneumonia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03007862
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11
- **Primary completion:** 2018-05
- **Final completion:** 2019-05
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2017-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03007862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03007862, "Bronchial Alpha Amylase as a Marker for Early Aspiration Pneumonia in Therapeutic Hypothermia.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03007862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*